Sort
46,585 grants matching “heart failure”
EVALUATION OF THE CARDIAC AND METABOLIC EFFECTS OF SEMAGLUTIDE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
$5,047,034Mayo Clinic · · FY2022 · Defense Health Agency
NDC for the Optical Control of Biological Function
$5,039,000Ehud Isacoff · University Of California Berkeley · PN2 · FY2010 · EY
A heterochronic model for birth defects in Down Syndrome
$5,035,031Ivan Paul Moskowitz · University Of Chicago · R01 · FY2023 · HD
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$5,000,071Keri, Hammel · The Emmes Company, Llc · N01 · FY2012 · EY
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
$4,985,286Scott David Solomon · Brigham And Women'S Hospital · U01 · FY2019 · HL
ASPirin in Reducing Events in the Elderly
$4,941,881Anne M Murray · Hennepin Healthcare Research Institute · U01 · FY2017 · AG
ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)
$4,930,145Lisa P Jacobson · Johns Hopkins University · U24 · FY2016 · OD
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
$4,883,546Gary M Felker · Duke University · R01 · FY2013 · HL
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$4,875,891Michele K Evans · National Institute On Aging · ZIA · FY2023 · AG
Healthy Aging In Neighborhoods of Diversity Across the Life Span (HANDLS)
$4,845,610Michele K Evans · National Institute On Aging · ZIA · FY2018 · AG
GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
$4,767,581Gary M Felker · Duke University · R01 · FY2016 · HL
1/2 REPRIEVE Extension for Trial Completion
$4,747,407Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2024 · HL
Heart Failure Clinical Research Network Coordinating Center
$4,745,879Kevin J Anstrom · Duke University · U10 · FY2013 · HL
PEDIAFLOW-TREATMENT FOR CONGENITAL HEART FAILURE IN INFANTS AND CHILDREN
$4,704,882Cornell University · · FY2020 · Defense Health Agency
BRIDGE TRIAL
$4,673,187Thomas L Ortel · Duke University · U01 · FY2010 · HL
Bridge2AI: Voice as a Biomarker of Health - Building an ethically sourced, bioaccoustic database to understand disease like never before
$4,660,942Yael Emilie Bensoussan · University Of South Florida · OT2 · FY2025 · OD
Comprehensive Structural and Functional Mapping of the Mammalian Cardiac Nervous System
$4,653,756Kalyanam Shivkumar · University Of California Los Angeles · OT2 · FY2018 · OD
GENERAL CLINICAL RESEARCH CENTER
$4,636,000University Of Colorado Denver · M01 · FY2001 · RR
Framingham Project/Levy
$4,598,189Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
ACHIEVE GreatER: Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region
$4,591,452Phillip David Levy · Wayne State University · P50 · FY2025 · MD
Framingham Project/Levy
$4,538,289Daniel Levy · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
STICH Trial-Coordinating Center
$4,494,631Duke University · U01 · FY2003 · HL
Early EMS and ED Use of GIK for ACS: The IMMEDIATE Trial
$4,444,879Tufts Medical Center · U01 · FY2004 · HL
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
$4,407,564Rebecca Li · New England Research Institutes, Inc. · N01 · FY2009 · HL
Heart Failure Clinical Research Network - DCC
$4,390,186Kerry L Lee · Duke University · U01 · FY2011 · HL